Current Biology
Volume 8, Issue 18, 10 September 1998, Pages 1001-1008
Journal home page for Current Biology

Research paper
Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade

https://doi.org/10.1016/S0960-9822(07)00420-4Get rights and content
Under an Elsevier user license
open archive

Abstract

Background: Fas (APO-1/CD95) is a member of the tumor necrosis factor receptor (TNF-R) family and induces apoptosis when crosslinked with either Fas ligand or agonistic antibody (Fas antibody). The Fas–Fas ligand system has an important role in the immune system where it is involved in the downregulation of immune responses and the deletion of peripheral autoreactive T lymphocytes. The intracellular domain of Fas interacts with several proteins including FADD (MORT-1), DAXX, RIP, FAF-1, FAP-1 and Sentrin. The adaptor protein FADD can, in turn, interact with the cysteine protease caspase-8 (FLICE/MACH/Mch5).

Results: In a genetic screen for essential components of the Fas-mediated apoptotic cascade, we isolated a Jurkat T lymphocyte cell line deficient in caspase-8 that was completely resistant to Fas-induced apoptosis. Complementation of this cell line with wild-type caspase-8 restored Fas-mediated apoptosis. Fas activation of multiple caspases and of the stress kinases p38 and c-Jun NH2-terminal kinase (JNK) was completely blocked in the caspase-8-deficient cell line. Furthermore, the cell line was severely deficient in cell death induced by TNF-α and was partially deficient in cell death induced by ultraviolet irradiation, adriamycin and etoposide.

Conclusions: This study provides the first genetic evidence that caspase-8 occupies an essential and apical position in the Fas signaling pathway and suggests that caspase-8 may participate broadly in multiple apoptotic pathways.

Cited by (0)

P Juo, J Yuan and J Blenis, Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA.

CJ Kuo, Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, and Dana Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA.

E-mail address for J Blenis (corresponding author): [email protected].